Image

NIBP Validation Study

NIBP Validation Study

Recruiting
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to compare measurements of blood pressure (BP) between the Philips non-invasive blood pressure (NIBP) system (including NIBP cuff and portable patient monitor) and invasive radial arterial line (A-line) in critical care patients.

Description

This is a multicenter, multi-phase, prospective, non-randomized, self-controlled, observational study to evaluate the validity of Philips non-invasive blood pressure technology.

This study is designed for the purpose of establishing equivalence of the Philips NIBP system with the gold standard arterial line.

Main Phase will be considered complete when the number of pre-defined subjects and data points are achieved per subject group.

  • Subject Group 1: Neonates, Infant, Children <3 years of age Minimum of 24 subjects and 180 data points
  • Subject Group 2: children 3-12 years of age Minimum of 41 subjects and 205 data points
  • Subject Group 3: Adolescent/Adult >12 years of age Minimum of 124 subjects and 620 data points

Eligibility

Inclusion Criteria:

  • Patient admitted into the Neonatal Intensive Care Unit (NICU), Pediatric Intensive Care Unit (PICU), or Intensive Care Unit (ICU)
  • Adult aged 18 years and older, or parent/legal guardian of minor, willing and able to understand and provide informed consent/assent
  • Indication for NIBP cuff
  • Indication for radial arterial line

Exclusion Criteria:

  • Inability to place the study device appropriately due to patient's anatomy or condition
  • Known pregnancy or lactating women (self-report)
  • Patients treated with an intra-aortic balloon pump
  • Aortic and mitral regurgitation (> 2nd degree)
  • Measurements taken in the lateral position
  • Currently participating in another clinical trial with any product, treatment and/or medication that clinically interferes with the study endpoint(s)
  • Currently receiving vasopressors during data collection
  • If valid SBP reference measurements for lateral difference is > 15 mmHg
  • If valid DBP reference measurements for lateral difference is > 10 mmHg
  • At the Principal Investigator's discretion, subject does not qualify to participate in the study for any reasons that are not mentioned above

Study details
    Critical Illness

NCT05673408

Philips Clinical & Medical Affairs Global

20 March 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.